SynthesisFrontiers in cellular and infection microbiology2026
Data-driven Atlas of
Synthesis in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: Publications from 2011 to 2025 were retrieved from the Web of Science Core Collection and Scopus. After integration, deduplication, and independent screening, 243 publications were included. Bibliometric and visualization analyses were performed using bibliometrix, CiteSpace, and VOSviewer. Results: Research output showed an overall nonlinear increase, with an annual growth rate of 18.68%. Iran, China, and the United States were the leading contributors, whereas international collaboration accounted for 19.75% of publications. Keyword analysis identified seven major thematic clusters centered on outer membrane vesicles, bacterial antigens, antimicrobial resistance, computational approaches, and immunization strategies. Temporal analyses showed increasing attention to bioinformatics, reverse vaccinology, peptide/epitope-based design, and virulence-associated targets. Citation analysis further highlighted OMV/OMC-based vaccination and several defined antigens as important components of the field's intellectual foundation. Discussion: Overall,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.